The treatment with T cell fraction containing adiponectin‐expressing Tregs, designated A‐TregTF significantly inhibited the growth and metastasis of orthotopically transplanted triple negative breast cancer cells. Here, ADIPOQ is linked to triple-negative breast carcinoma.